Fundamentals

Valuation

Metric	Q2	Q4	Δ in %
EV/EBITDA	0.72	8.89	8.83
Graham Fair Price	-14.87	19.53	22.95
PEG	-66.79	0.04	0.13
Price/Book	-6.13	1.21	1.29
Price/Cash Flow	310.31	1033.49	251.88
Prices/Earnings	15.71	-7.62	6.59
Price/Sales	-5.70	2.00	2.12
Price/FCF	310.31	1033.49	251.88
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q2	Q4	Δ in %
Gross Profit Margin	-6.71	0.20	0.22
Operating Margin	-6.71	0.20	0.22
ROA	-23.16	-0.01	0.02
ROE	0.05	-0.04	-18.87
ROIC	0.05	-0.10	113.75
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q4	Δ in %
Debt QOQ	0.05	0.13	-64.12
Dividends QOQ	-0.40	-0.27	31.61
EBIT QOQ	-0.39	-0.12	68.52
EPS QOQ	0.51	-1.77	248.36
FCF QOQ	-0.87	-0.78	9.49
Revenue QOQ	-0.07	-0.06	16.98
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q2	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	47.00	47.53	1.12
Days Sales Outstanding (DSO)	20.95	27.73	32.36
Inventory Turnover	1.91	1.89	-1.11
Debt/Capitalization	0.38	0.40	6.42
Quick Ratio	1.44	1.16	-19.66
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q2	Q4	Δ in %
Book Value	21.87	20.67	-5.49
Cash	6.51	5.06	-22.28
Capex	-2.38	-2.65	-11.39
Free Cash Flow	0.11	0.02	-78.38
Revenue	13.32	12.53	-5.92
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q2	Q4	Δ in %
Current Ratio	2.28	1.85	-18.88
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.73	2.34	35.29
Naive Interpretation	Member

06 - Financial Health · Weak

Rating